Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension study of E2007 in levodopa-treated Parkinson's disease with motor fluctuations
2007-000801-30Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2007
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of perampanel in Parkinson's disease (PD), sponsored by Eisai Co., Ltd. Primary endpoints: Long-term safety and tolerability, Long-term efficacy maintenance and 2 more. Started Jun 2007; status: completed.
02
Drugs
perampanel
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2007-000801-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000801-30.